Secretary Robert F. Kennedy Jr. has made psychiatric medications a focus of his review of the country’s childhood chronic ...
A recent modification to the contract would have allowed Vaxart to invoice BARDA for the remaining $230 million or so for ...
Rare Disease Symposium, held on February 5 in Boston and virtually, gathered patient advocates and caregivers, providers, ...
7h
Intelligencer on MSNAll the Firing, Layoffs and Resignations We Know OfIf you’re a federal worker affected by the ongoing layoffs with information relevant to keeping our coverage updated, feel ...
The pathologists group wants the HHS to terminate the regulation in light of an executive order from President Trump that calls for federal agencies to “alleviate unnecessary regulatory burdens.” ...
Childhood psychiatrists insist the drugs, for attention-deficit/hyperactivity disorder (ADHD) and depression, are nonaddictive and proven safe and say they are more concerned about young Americans ...
Patient advocacy groups had decried the firings, and lobbying groups rushed to save some slots that were in part funded by ...
Robert F. Kennedy Jr. is making moves that could affect immunization uptake and policy in the U.S., while Oracle submits a ...
The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the ...
This is a developing story. If you are a dismissed or active federal worker with information to share, please reach out at ...
In letter, senators say recent staff firings could affect drug and device approval, food safety and public health threats.
"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results